Scarica l'app Stockscreener
10.46
3.86%
-0.42
Dopo l'orario di chiusura:
10.42
-0.04
-0.38%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$10.88
Aprire:
$10.89
Volume 24 ore:
770.79K
Relative Volume:
1.10
Capitalizzazione di mercato:
$365.90M
Reddito:
$2.07M
Utile/perdita netta:
$-47.68M
Rapporto P/E:
-3.7092
EPS:
-2.82
Flusso di cassa netto:
$-31.31M
1 W Prestazione:
-5.77%
1M Prestazione:
-5.94%
6M Prestazione:
-0.66%
1 anno Prestazione:
+27.87%
Intervallo 1D:
$10.46
$10.97
Intervallo di 1 settimana:
$10.46
$11.40
Portata 52W:
$8.1598
$18.23
Delcath Systems Inc Stock (DCTH) Company Profile
Nome
Delcath Systems Inc
Settore
Industria
Telefono
(518) 743-8892
Indirizzo
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Confronta DCTH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
10.46 | 380.60M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-28 | Iniziato | Craig Hallum | Buy |
| 2024-05-14 | Iniziato | Stephens | Overweight |
| 2022-07-26 | Ripresa | Canaccord Genuity | Buy |
| 2021-12-10 | Iniziato | H.C. Wainwright | Buy |
| 2021-03-09 | Iniziato | Canaccord Genuity | Buy |
| 2021-01-05 | Iniziato | BTIG Research | Buy |
| 2020-06-01 | Iniziato | Laidlaw | Buy |
Mostra tutto
Delcath Systems Inc Borsa (DCTH) Ultime notizie
Evaluating Delcath Systems Inc. with trendline analysis2025 Retail Activity & AI Driven Price Forecasts - newser.com
Tools to assess Delcath Systems Inc.’s risk profileWeekly Trend Summary & Long Hold Capital Preservation Tips - newser.com
Is Delcath Systems Inc a good long term investmentEconomic Data Impact & High Return Market Tips - earlytimes.in
Detecting price anomalies in Delcath Systems Inc. with AIWeekly Stock Analysis & Free Weekly Watchlist of Top Performers - newser.com
Using Python tools to backtest Delcath Systems Inc. strategiesTrade Risk Report & Detailed Earnings Play Alerts - newser.com
What to expect from Delcath Systems Inc. in the next 30 days2025 Bull vs Bear & Daily Volume Surge Signals - newser.com
What Fibonacci levels say about Delcath Systems Inc. rebound2025 Valuation Update & High Yield Stock Recommendations - newser.com
How to forecast Delcath Systems Inc. trends using time seriesEarnings Recap Summary & Fast Entry Momentum Trade Alerts - newser.com
Delcath Systems (NASDAQ:DCTH) Given Hold (C-) Rating at Weiss Ratings - MarketBeat
Will Delcath Systems Inc. (DV3R) stock outperform Dow JonesWeekly Trade Recap & Breakout Confirmation Alerts - newser.com
Advanced analytics toolkit walkthrough for Delcath Systems Inc.Earnings Performance Report & Precise Swing Trade Entry Alerts - newser.com
Candlestick signals on Delcath Systems Inc. stock todayFed Meeting & Growth Focused Stock Pick Reports - newser.com
Why global investors buy Delcath Systems Inc. (DV3R) stock2025 Support & Resistance & Verified Chart Pattern Trade Signals - newser.com
What does recent volatility data suggest for Delcath Systems Inc.Market Risk Summary & Safe Entry Trade Signal Reports - newser.com
Delcath Systems (DCTH): Evaluating Valuation After CHOPIN Phase 2 Trial Results Announcement for Uveal Melanoma - Sahm
Delcath Systems Inc DV3R Stock Analysis and ForecastEconomic Data Impact & Use Smart Algorithms to Pick Better Stocks - earlytimes.in
Is Delcath Systems Inc. stock cheap at current valuationMarket Activity Report & Expert-Curated Trade Recommendations - newser.com
Pattern recognition hints at Delcath Systems Inc. upsideEarnings Growth Report & Free Expert Verified Stock Movement Alerts - newser.com
Published on: 2025-10-05 05:55:28 - newser.com
Why Delcath Systems Inc. (DV3R) stock stays undervaluedInsider Buying & Free Technical Pattern Based Buy Signals - newser.com
What MACD signals say about Delcath Systems Inc.Trade Ideas & Real-Time Price Movement Reports - newser.com
Wall Street Zen Upgrades Delcath Systems (NASDAQ:DCTH) to “Buy” - Defense World
Wall Street Zen Upgrades Delcath Systems (NASDAQ:DCTH) to "Buy" - MarketBeat
Delcath Systems, Inc. (NASDAQ:DCTH) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Biliary Tract Cancer Market Expected to Gain Momentum Through 2034, According to DelveInsight | AstraZeneca, Taiho Oncology, Delcath Systems, TransThera Sciences (Nanjing), Basilea Pharma, Eisai - Barchart.com
Biliary Tract Cancer Market Expected to Gain Momentum Through - openPR.com
Nkarta Inc Stock Analysis and ForecastPrice Support Zones & Exceptional Profit Trading - earlytimes.in
Delcath sets outlook amid plans to enter National Medicaid Drug Rebate Agreement - MSN
Delcath Systems Inc Stock Analysis and ForecastEarnings Growth Projections & Investment Risk Management Tips - earlytimes.in
United States Uveal Melanoma Treatment Market Set to Soar with - openPR.com
Is Delcath Systems Inc DV3R a good long term investmentHigh Yield Income Stocks & Your Roadmap to 10x Returns Starts Here - earlytimes.in
DCTH Faces Defining Moment As CHOPIN Data Readout Nears At ESMO 2025 - RTTNews
Palisades Investment Partners LLC Grows Holdings in Delcath Systems, Inc. $DCTH - MarketBeat
Delcath Systems Inc Azioni (DCTH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Delcath Systems Inc Azioni (DCTH) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| MICHEL GERARD J | CHIEF EXECUTIVE OFFICER |
Oct 22 '24 |
Option Exercise |
6.00 |
16,666 |
99,996 |
319,334 |
1.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):